Exponent, Inc. (NASDAQ:EXPO) Short Interest Update

Exponent, Inc. (NASDAQ:EXPO) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 1,520,000 shares, a drop of 11.1% from the September 15th total of 1,710,000 shares. Based on an average daily volume of 196,200 shares, the days-to-cover ratio is currently 7.7 days. Approximately 3.0% of the company’s shares are short sold.

Insider Buying and Selling

In other news, VP John Pye sold 3,956 shares of the firm’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares in the company, valued at $2,984,310. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.10% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Bamco Inc. NY acquired a new stake in shares of Exponent during the 1st quarter worth $25,904,000. Vanguard Group Inc. raised its stake in Exponent by 5.8% during the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after acquiring an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Exponent by 6.5% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after acquiring an additional 284,179 shares during the last quarter. Assenagon Asset Management S.A. acquired a new stake in shares of Exponent in the 2nd quarter valued at approximately $22,050,000. Finally, Conestoga Capital Advisors LLC grew its holdings in shares of Exponent by 2.8% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock valued at $262,841,000 after purchasing an additional 75,909 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Analyst Ratings Changes

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Trading Down 1.3 %

Shares of NASDAQ:EXPO traded down $1.44 on Thursday, hitting $113.09. The company had a trading volume of 55,593 shares, compared to its average volume of 247,586. The stock has a 50 day moving average price of $108.45 and a 200 day moving average price of $98.81. The stock has a market cap of $5.73 billion, a price-to-earnings ratio of 57.84 and a beta of 0.66. Exponent has a 1-year low of $64.61 and a 1-year high of $115.75.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. Exponent had a net margin of 19.35% and a return on equity of 28.39%. The business had revenue of $132.43 million for the quarter, compared to analyst estimates of $130.83 million. During the same quarter in the prior year, the business earned $0.50 EPS. Exponent’s quarterly revenue was up 2.1% on a year-over-year basis. Sell-side analysts anticipate that Exponent will post 2.04 earnings per share for the current fiscal year.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were issued a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend was Friday, September 6th. Exponent’s dividend payout ratio is 56.57%.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.